Pgi14 Perceived Value Assessment of Entecavir Versus Tenofovir in Chronic Hepatitis B

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.02.1011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Letter: Distinct Hepatitis B Virus Relapse Rates After Discontinuing Tenofovir and Entecavir Therapy in Chronic Hepatitis B Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Tenofovir Plus Entecavir Combination Therapy for Chronic Hepatitis B With Nucleos(t)ide Analogue Failure

The European Research Journal
2020English

Comparison of Renal Safety and Efficacy of Telbivudine, Entecavir and Tenofovir Treatment in Chronic Hepatitis B Patients: Real World Experience

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2016English

Entecavir Treatment of Chronic Hepatitis D

Clinical Infectious Diseases
Infectious DiseasesMicrobiology
2012English

Long-Term Outcome of Entecavir Therapy in Chronic Hepatitis B With Cirrhosis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2020English

Renal Concerns in the Treatment of Chronic Hepatitis B With Tenofovir

Journal of Renal and Hepatic Disorders
2017English

Costo-Efectividad De Dos Terapias Antivirales Para Hepatitis B Crónica en El Perú: Entecavir Y Tenofovir

Revista Peruana de Medicina de Experimental y Salud Publica
MedicineEnvironmentalPublic HealthOccupational Health
2017English

Potential Effects of Telbivudine Versus Entecavir on Renal Function in Patients With Chronic Hepatitis B Virus Receiving Glucocorticoids Therapy

Therapeutic Apheresis and Dialysis
HematologyNephrology
2019English

Obesity and Hepatocellular Carcinoma in Patients Receiving Entecavir for Chronic Hepatitis B

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy